Evaluate Safety, Efficacy and Pharmacokinetics
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: CT-P6|DRUG: Herceptin|DRUG: Paclitaxel
Sponsor: Celltrion